New Zealand markets closed

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.6500+0.1300 (+5.16%)
At close: 04:00PM EDT
2.6000 -0.05 (-1.89%)
After hours: 06:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 592.17M
Enterprise value 204.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.12
Price/book (mrq)1.07
Enterprise value/revenue 3.81
Enterprise value/EBITDA -0.87

Trading information

Stock price history

Beta (5Y monthly) 2.51
52-week change 3-64.24%
S&P500 52-week change 323.57%
52-week high 312.3600
52-week low 32.2150
50-day moving average 33.0161
200-day moving average 35.3653

Share statistics

Avg vol (3-month) 3800.28k
Avg vol (10-day) 3758.89k
Shares outstanding 5224.31M
Implied shares outstanding 6224.31M
Float 8118.72M
% held by insiders 145.35%
% held by institutions 123.77%
Shares short (15 Apr 2024) 44.19M
Short ratio (15 Apr 2024) 45.39
Short % of float (15 Apr 2024) 410.54%
Short % of shares outstanding (15 Apr 2024) 41.87%
Shares short (prior month 15 Mar 2024) 44.86M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-364.18%

Management effectiveness

Return on assets (ttm)-20.60%
Return on equity (ttm)-49.55%

Income statement

Revenue (ttm)53.76M
Revenue per share (ttm)0.24
Quarterly revenue growth (yoy)93.10%
Gross profit (ttm)N/A
EBITDA -254.95M
Net income avi to common (ttm)-260.17M
Diluted EPS (ttm)-1.2600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)402.45M
Total cash per share (mrq)1.8
Total debt (mrq)41.82M
Total debt/equity (mrq)8.09%
Current ratio (mrq)2.57
Book value per share (mrq)2.31

Cash flow statement

Operating cash flow (ttm)-267.89M
Levered free cash flow (ttm)-151.51M